Novo Nordisk & Aspect Launch New Diabetes Cure Partnership
Novo Nordisk and Aspect Biosystems have restructured their 2023 collaboration, transferring select stem cell–derived islet and hypoimmune engineering technologies,...
BrightInsight Taps Execs for Global Growth & Innovation
BrightInsight has expanded its executive leadership team, appointing a new chief operating officer, a senior vice president overseeing market...
BrightInsight Unlocks Global Growth With New Leadership Hires
BrightInsight has expanded its executive bench, appointing Robert Zdon as chief operating officer, Eric Redline as senior vice president...
Avacta Announces Year-End Trading Update and Outlook
Avacta Therapeutics issued a year-end update signaling a pivotal 2026. The company’s tumor-activated Pre|CISION platform now has two programs...
NASDAQ Inducement Grants Reported by Iovance Biotherapeutics
Iovance Biotherapeutics has granted inducement stock options for 97,710 shares to 17 newly hired non-executive employees, priced at $2.22...
Virbac’s Surging Revenue: A Solid +7.9% Growth Dynamic
Virbac closed 2025 with €1.465 billion in revenue, up 7.9% organically at constant exchange rates and scope, with fourth-quarter...
Cosmos Health Soars, Supporting $40M in Added Revenue
Cosmos Health’s distribution arm, Cosmofarm, is accelerating its build-out in Greece. In 2025, the wholesaler added nearly 100 new...
Nasus Pharma Reports Positive Results for Intranasal NS002
Nasus Pharma reported positive interim Phase 2 data for NS002, an intranasal powder formulation of epinephrine for anaphylaxis, demonstrating...
Telix Soars Past FY25 Goals with $1.2B Revenue, New Launch
Telix Pharmaceuticals reported unaudited Q4 2025 group revenue of approximately $208 million, up 46% year over year, bringing full-year...
MyoCardia China Pipeline Activated, Final NMPA Submission Nears
Cardiac Biotech Solutions has initiated China-based manufacturing and regulatory preparation for its MyCardia AT ambulatory cardiac event monitor through...